GossipQueen
New Member
- Joined
- Jan 20, 2007
- Messages
- 98
Human embryonic stem cells can repair damaged hearts, according to animal research published on Monday.
If the results are confirmed in clinical trials, heart disease may be a multibillion dollar market for stem cell therapies.
Scientists at the University of Washington and Geron, the California-based biotechnology company, implanted cardiac cells derived from human embryonic stem cells into rats four days after a heart attack. They helped rebuild the animals’ heart muscles and improved the functioning of the whole heart.
Tom Okarma, Geron chief executive, said the “landmark study” – published by the journal Nature Biotechnology – was the first to demonstrate convincingly that embryonic stem cells could treat hearts weakened by an infarction or heart attack. Five million people in the US suffering from heart failure could benefit.
Source
If the results are confirmed in clinical trials, heart disease may be a multibillion dollar market for stem cell therapies.
Scientists at the University of Washington and Geron, the California-based biotechnology company, implanted cardiac cells derived from human embryonic stem cells into rats four days after a heart attack. They helped rebuild the animals’ heart muscles and improved the functioning of the whole heart.
Tom Okarma, Geron chief executive, said the “landmark study” – published by the journal Nature Biotechnology – was the first to demonstrate convincingly that embryonic stem cells could treat hearts weakened by an infarction or heart attack. Five million people in the US suffering from heart failure could benefit.
Source